The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

Ava Labs, Inc.

Ithaca, New York

AVA Labs makes finance applications using blockchain technology–with highly scalable and efficient networks, customizable public and private blockchains.

C2i Genomics Inc.

Cresskill, New Jersey

C2i Genomics helps doctors and patients fight cancer by providing doctors and patients with tumor burden information, starting with only a blood sample.

Dynamic Locomotion, Inc.

Groton, New York

Faeth Therapeutics, Inc.

Oakland, California

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of next-generation cellular immunotherapies for cancer and immune disorders.

Inso Biosciences, Inc.

Ithaca, New York

Inso Biosciences (formerly Tico Biosciences) is developing a cell sample preparation platform designed to perform cellular sample processing. The company’s platform separates and isolates cellular components, enabling users to perform long-read DNA sequencing and multi-omic analysis.

LEXEO Therapeutics, LLC

New York, NY

LEXEO Therapeutics is a New York City based clinical stage gene therapy biotechnology company with a focus on hereditary and acquired diseases of high unmet need.


Delray Beach, Florida

OneThree Biotech, Inc.

Astoria, New York

OneThree Biotech is a VC backed startup developing a biology-driven Artificial Intelligence Technology Platform to accelerate drug discovery and development.

OWiC Technologies, Inc.

Ithaca, New York

Developer of microscopic optical smart ID tags.

Ship of Theseus LLC

Philadelphia, Pennsylvania

A bioengineering company that focuses on stem cell therapies for aging and age-associated disease.

Swiftscale Biologics, Inc.

San Francisco, California

Swiftscale Biologics provides fast production services for biologics. At any scale from micrograms to grams, Swiftscale can produce proteins. Swiftscale can produce antibodies, enzymes, receptors, and other complex protein forms. Swiftscale was co-founded by Matthew DeLisa, a professor at Cornell, and Michael Jewett, a professor at Northwestern.

Uni Creative, Inc.

Brooklyn, New York

Uni actualizes inclusion by radically transforming how companies make smart decisions.

Volastra Therapeutics, Inc.

New York, New York

Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.

CTL Logo


Current annual report


Previous annual reports